Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
نویسندگان
چکیده
منابع مشابه
Successful treatment of nephrotic syndrome in twin pregnancy: case report
Background: Nephrotic syndrome is a kidney disorder that is identified by signs of nephrosis, severe proteinuria, hypoalbuminemia, and edema. It is a component of glomerulonephrosis, in which different degrees of proteinuria may occur. The complications of this syndrome may include blood clots, infections, and high blood pressure. Essentially, decreased protein through the kidneys (proteinuria)...
متن کاملTreatment of nephrotic syndrome.
There are well defined therapeutic protocols for childhood nephrotic syndrome. Appropriate therapy helps in minimizing side effects besides decreasing referrals to tertiary care centres. We have analysed the appropriateness of therapy of primary care physicians in 111 children with nephrotic syndrome referred to our Institute from January 1989 to December 1991. Prednisone was administered in ad...
متن کاملChildhood Nephrotic Syndrome (Nephrosis) — Treatment and Complications
Nephrotic syndrome is a common renal disorder in children, characterized by nephrotic range proteinuria, hypoalbuminemia, hyperlipidemia, and edema. The most common type is primary (idiopathic) associated with minimal change disease, which responds very well to steroid therapy and has a good long-term prognosis. Other causes, clinical presentation, laboratory findings, and management are discus...
متن کاملCyclophosphamide in Treatment of Nephrotic Syndrome
SIR,-Your leading article on this subject (4 December, p. 613) was no doubt justified by the recent reports you quoted. There was, however, one outstanding flaw in your review which was to my mind almost criminally negligent. You did not draw attention to the fact that it was in the cases treated in an ambulant manner that paraplegia developed during treatment. I feel that you should draw atten...
متن کاملRituximab Treatment for Nephrotic Syndrome in Children
In the past 10 years, many reports have suggested that rituximab, a chimeric anti-CD20 monoclonal antibody, is effective for children with complicated, frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, those reports were case reports, case series, retrospective surveys, and single-arm or short-term trials. Therefore, well-designed controlled trials are required ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Nephrology
سال: 2017
ISSN: 1759-5061,1759-507X
DOI: 10.1038/nrneph.2017.155